GI Stool Testing Market Size & Share Report, 2025 to 2034

GI Stool Testing Market – By Product Type, By Test Type, By Application, By Distribution Channel, By End Use – Global Forecast, 2025 to 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increase in prevalence of gastrointestinal disorders

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancements in stool testing instruments

3.2.1.3&nbsp;&nbsp;&nbsp; Increasing adoption of at-home stool testing kits

3.2.1.4&nbsp;&nbsp;&nbsp; Growing demand for early diagnosis and prevention of GI diseases

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Lack of skilled professionals

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory policies

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Pricing analysis, 2024

3.5&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.6&nbsp;&nbsp;&nbsp; Regulatory landscape

3.7&nbsp;&nbsp;&nbsp; Technology landscape

3.8&nbsp;&nbsp;&nbsp; Gap analysis

3.9&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.10&nbsp;&nbsp;&nbsp; PESTEL analysis

3.11&nbsp;&nbsp;&nbsp; Future market trends

3.12&nbsp;&nbsp;&nbsp; Value chain analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product Type, 2021 &ndash; 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Consumables

5.3&nbsp;&nbsp;&nbsp; Analyzers

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Test Type, 2021 &ndash; 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Occult blood test

6.2.1&nbsp;&nbsp;&nbsp; Immuno FOB agglutination test

6.2.2&nbsp;&nbsp;&nbsp; Immuno FOB ELISA test

6.2.3&nbsp;&nbsp;&nbsp; Lateral flow immuno FOB test

6.2.4&nbsp;&nbsp;&nbsp; Guaiac FOB stool test

6.3&nbsp;&nbsp;&nbsp; Bacteria test

6.4&nbsp;&nbsp;&nbsp; Fecal biomarkers test

6.4.1&nbsp;&nbsp;&nbsp; Tumor M2-PK stool test

6.4.2&nbsp;&nbsp;&nbsp; Transferrin assays

6.4.3&nbsp;&nbsp;&nbsp; Other fecal biomarkers tests

6.5&nbsp;&nbsp;&nbsp; Ova and parasites test

6.6&nbsp;&nbsp;&nbsp; Other test types

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Infection

7.3&nbsp;&nbsp;&nbsp; Cancer

7.4&nbsp;&nbsp;&nbsp; Inflammatory bowel disease

7.5&nbsp;&nbsp;&nbsp; Gastroesophageal reflux disease (GERD)

7.6&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 &ndash; 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Brick and mortar

8.3&nbsp;&nbsp;&nbsp; E-commerce

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 &ndash; 2034 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Hospitals and clinics

9.3&nbsp;&nbsp;&nbsp; Diagnostic centers

9.4&nbsp;&nbsp;&nbsp; Homecare settings

9.5&nbsp;&nbsp;&nbsp; Other end users

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2034 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp;U.S.

10.2.2&nbsp;&nbsp;&nbsp;Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp;Germany

10.3.2&nbsp;&nbsp;&nbsp;UK

10.3.3&nbsp;&nbsp;&nbsp;France

10.3.4&nbsp;&nbsp;&nbsp;Spain

10.3.5&nbsp;&nbsp;&nbsp;Italy

10.3.6&nbsp;&nbsp;&nbsp;Netherlands

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp;China

10.4.2&nbsp;&nbsp;&nbsp;Japan

10.4.3&nbsp;&nbsp;&nbsp;India

10.4.4&nbsp;&nbsp;&nbsp;Australia

10.4.5&nbsp;&nbsp;&nbsp;South Korea

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp;Brazil

10.5.2&nbsp;&nbsp;&nbsp;Mexico

10.5.3&nbsp;&nbsp;&nbsp;Argentina

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

10.6.1&nbsp;&nbsp;&nbsp;South Africa

10.6.2&nbsp;&nbsp;&nbsp;Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp;UAE

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

11.2&nbsp;&nbsp;&nbsp; danaher

11.3&nbsp;&nbsp;&nbsp; BIO RAD

11.4&nbsp;&nbsp;&nbsp; BIOMRIEUX

11.5&nbsp;&nbsp;&nbsp; CardinalHealth

11.6&nbsp;&nbsp;&nbsp; Cenogenics

11.7&nbsp;&nbsp;&nbsp; CTK BIOTECH

11.8&nbsp;&nbsp;&nbsp; Diasorin

11.9&nbsp;&nbsp;&nbsp; EDI

11.10&nbsp;&nbsp;&nbsp; GENOVA DIAGNOSTICS

11.11&nbsp;&nbsp;&nbsp; meridian BIOSCIENCE

11.12&nbsp;&nbsp;&nbsp; Quest Diagnostics

11.13&nbsp;&nbsp;&nbsp; ScheBo Biotech

11.14&nbsp;&nbsp;&nbsp; SIEMENS

&nbsp;&nbsp;&nbsp;

GI Stool Testing Market

Request Discount

Industries

Information

Link

Global Headquarters